Travel Time for Breast Cancer Screening Remains Long for Many Women in the U.S., New Study Shows. Credit: American Cancer Society

Travel Time for Breast Cancer Screening Remains Long for Many Women in the U.S., New Study Shows. Credit: American Cancer Society 


December 19, 2022 —  A new study led by researchers at the American Cancer Society (ACS) shows travel time to the nearest mammography facility is long for a considerable proportion of women in the United States, particularly affecting more than 50% of women in rural areas in 28 states. This poor geographic accessibility was associated with a lower number of women getting important breast cancer screening. The study was published today in the Journal of the National Cancer Institute (JNCI). 

“Our findings are concerning. Mammography is widely available in the United States, but barriers, such as long drive times, are likely influencing a woman’s decision to get screened,” said Dr. Daniel Wiese, senior scientist, cancer disparity research at t­­­­he American Cancer Society and lead author of the study. “We need to move forward on programs to remove these barriers so women can access this potentially life-saving screening.” 

For the study, researchers obtained mammography location data in the contiguous U.S. (District of Columbia and all states except Alaska and Hawaii) in 2006 and 2022 by census tract (73,718) from the U.S. Food and Drug Administration. Scientists estimated the number and proportion of women aged 45-84 years who had limited travel-time-based geographic accessibility (drive time greater than 20 minutes) to the nearest mammography facility by urban-rural status and state from 2006 to 2022. Researchers then evaluated associations between limited accessibility and breast cancer screening prevalence by state. 

The results showed, nationwide, the proportion of women with limited accessibility to mammography remains high. This proportion did not substantially change from 2006 (12.7%) to 2022 (12.2%), however, because of population growth, the estimated number of women with limited accessibility increased from 7.5 million in 2006 to 8.2 million in 2022. In 10 states, the data showed more than 26% of women had limited accessibility to mammography, primarily in the Rocky Mountains and the South regions. Except for a few states in the New England and Mid-Atlantic regions, limited accessibility to mammography was substantial in rural areas (greater than 50% in 28 states), with highest proportions in the Rocky Mountains region. In urban areas, this proportion was less than 5.0% in 35 states. The largest improvements were in South Dakota and Mississippi, where limited accessibility declined by 5.1% and 4.8%, respectively. 

“The simple answer would be to open more breast cancer screening facilities in sparsely populated areas, but this can be economically and logistically challenging,” Wiese added. “Providing transportation or promoting the use of mobile screening units may be alternative actions, although further research is needed to improve the effectiveness of mobile screening units in increasing participation in breast cancer screening in rural areas.”  Dr. Farhad Islami, senior scientific director, cancer disparity research at the American Cancer Society also participated in this study. 

For more information: www.cancer.org 

Related Content: 

High Deductible Leads Women to Skip Testing after Abnormal Mammogram 

RSNA Launches Screening Mammography Breast Cancer Detection AI Challenge 

Revolutionizing Women’s Health with One-day Diagnosis 

Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis 

Today's Mammography Advancements  

Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings  

AI DBT Impact on Mammography Post-breast Therapy  

ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI  

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs  

Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography 

Study Finds Racial Disparities in Access to New Mammography Technology 

American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation 


Related Content

Feature | Breast Imaging

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...

Time October 24, 2025
arrow
News | Breast Imaging

Oct. 15, 2025 — Leading into Breast Cancer Awareness Month, Fujifilm Healthcare Americas Corp. and Beekley Medical ...

Time October 15, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 – Clairity Inc., a leader in AI-based breast cancer risk prediction, will make five scientific ...

Time October 07, 2025
arrow
News | Breast Imaging

Oct. 3, 2025 — Gnosis for Her, a mobile breast health initiative redefining comfort and access in women's breast imaging ...

Time October 06, 2025
arrow
News | Mammography | Mayo Clinic

Early detection is key to breast cancer survival. But nearly half of all women in the U.S. have dense breast tissue ...

Time October 03, 2025
arrow
News | Mammography

Sept. 26, 2025 — Data from two groundbreaking studies evaluating the performance of Hologic’s artificial intelligence ...

Time October 02, 2025
arrow
News | PACS

Sept. 25, 2025 — RamSoft Inc., a provider of cloud-based RIS/PACS radiology solutions, has announced a new ...

Time September 26, 2025
arrow
News | Radiopharmaceuticals and Tracers

Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative ...

Time September 18, 2025
arrow
News | Women's Health

Sept. 15, 2025 — GE HealthCare has launched the Voluson Performance series, the latest addition to its women’s health ...

Time September 15, 2025
arrow
News | Mammography

Sept. 3, 2025 — According to ARRS’ American Journal of Roentgenology (AJR), a commercial artificial intelligence (AI) ...

Time September 09, 2025
arrow
Subscribe Now